Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,111,575
+$711,615 QoQ
Shares Held
11,946
+165.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#127
of 282 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Jun 30, 2026CallValue
$1,861,000
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. BNTX ranks #43 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in BNTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,861,000 | 20,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $1,111,575 | 11,946 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $399,960 | 4,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $666,400 | 7,000 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $2,848,750 | 25,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $2,848,750 | 25,000 | Put | Sole | 2025-02-14 | |
| 2023-09-30 | $1,075,536 | 9,900 | Shares | Sole | 2023-11-14 | |
| 2021-12-31 | $3,222,500 | 12,500 | Put | Sole | 2022-02-11 | |
| 2021-12-31 | $567,160 | 2,200 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $54,598 | 200 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $3,412,375 | 12,500 | Put | Sole | 2021-11-12 | |
| 2020-09-30 | $22,942,822 | 331,400 | Put | Sole | 2020-11-16 | |
| 2020-06-30 | $1,121,232 | 16,800 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||